Eric dEsparbes - 15 Feb 2024 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)

Role
Chief Financial Officer
Signature
/s/ Clarke Neumann, Attorney-in-Fact for Eric d'Esparbes
Issuer symbol
BIORQ
Transactions as of
15 Feb 2024
Net transactions value
$0
Form type
4
Filing time
15 Feb 2024, 16:05:20 UTC
Previous filing
17 Aug 2023
Next filing
16 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOR Common Stock Award $0 +325,000 +117% $0.000000 603,662 15 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 325,000 restricted stock units, 25% of which will vest on February 15, 2025, with the remaining shares vesting in equal semi-annual installments through February 15, 2028, subject to the Reporting Person's continued service to the Issuer.